These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11251713)

  • 1. Butterscotch masks the bitter taste of sumatriptan nasal spray.
    Blumenthal HJ
    Headache; 2001 Feb; 41(2):210. PubMed ID: 11251713
    [No Abstract]   [Full Text] [Related]  

  • 2. How does sumatriptan nasal spray perform in clinical practice?
    Dahlöf CG; Boes-Hansen S; Cederberg CG; Hardebo JE; Henriksson A
    Cephalalgia; 1998 Jun; 18(5):278-82. PubMed ID: 9673808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies.
    Ryan R; Elkind A; Baker CC; Mullican W; DeBussey S; Asgharnejad M
    Neurology; 1997 Nov; 49(5):1225-30. PubMed ID: 9371898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug-clinics. The drug of the month. Imitrex nasal spray (sumatriptan)].
    Scheen AJ
    Rev Med Liege; 1997 Sep; 52(9):610-2. PubMed ID: 9441347
    [No Abstract]   [Full Text] [Related]  

  • 5. Parental satisfaction with sumatriptan nasal spray in childhood migraine.
    Pakalnis A; Kring D; Paolicchi J
    J Child Neurol; 2003 Nov; 18(11):772-5. PubMed ID: 14696905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of new therapeutic deliveries in migraine.
    Dahlöf C
    Neurology; 2003 Oct; 61(8 Suppl 4):S31-4. PubMed ID: 14581656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of nasal sumatriptan in 5- to 12-year-old children.
    Hershey AD; Powers SW; LeCates S; Bentti AL
    Headache; 2001; 41(7):693-7. PubMed ID: 11554957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children.
    Callenbach PM; Pels LP; Mulder PG; Linssen WH; Gooskens RH; van der Zwan JL; Brouwer OF;
    Eur J Paediatr Neurol; 2007 Nov; 11(6):325-30. PubMed ID: 17428708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies.
    Dahlöf C
    Cephalalgia; 1999 Nov; 19(9):769-78. PubMed ID: 10595285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onzetra Xsail--sumatriptan nasal powder.
    Med Lett Drugs Ther; 2016 Jul; 58(1499):92-3. PubMed ID: 27403783
    [No Abstract]   [Full Text] [Related]  

  • 12. Newer intranasal migraine medications.
    Logemann CD; Rankin LM
    Am Fam Physician; 2000 Jan; 61(1):180-6. PubMed ID: 10643958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of clinical safety data for sumatriptan nasal powder administered by a breath powered exhalation delivery system in the acute treatment of migraine.
    Silberstein SD
    Expert Opin Drug Saf; 2018 Jan; 17(1):89-97. PubMed ID: 28994319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of intranasal sumatriptan.
    Fuseau E; Petricoul O; Moore KH; Barrow A; Ibbotson T
    Clin Pharmacokinet; 2002; 41(11):801-11. PubMed ID: 12190330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
    Natarajan S; Jabbour JT; Webster CJ; Richardson MS
    Headache; 2004; 44(10):969-77. PubMed ID: 15546259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
    Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE
    Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet.
    Lines C; Visser WH
    Int J Clin Pract; 2004 Mar; 58(3):322; author reply 322-3. PubMed ID: 15117106
    [No Abstract]   [Full Text] [Related]  

  • 19. Sumatriptan in the acute treatment of migraine without aura: efficacy of 50-mg dose.
    Moschiano F; D'Amico D; Grazzi L; Leone M; Bussone G
    Headache; 1997; 37(7):421-3. PubMed ID: 9277024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study.
    Farmer K; Cady R; Bleiberg J; Reeves D; Putnam G; O'Quinn S; Batenhorst A
    Headache; 2001 Apr; 41(4):377-84. PubMed ID: 11318884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.